Investor Moves
| Name | Value | Action | Change | Price | Last Price |
|---|---|---|---|---|---|
Ken GriffinCitadel Advisors $-11.6K ExitQ1 2026 $12k -- $10.10 | |||||
Ken GriffinCitadel Advisors $-32.6K ExitQ3 2025 $33k -- $10.10 | |||||
News
gurufocus.comExelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026gurufocus.comMay 30
gurufocus.comLabcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancergurufocus.comMay 29
seekingalpha.comNTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 28
gurufocus.comImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United Statesgurufocus.comMay 16
globenewswire.comNeo-Concept International Announces Share Consolidationglobenewswire.comMay 15